MicroRNAs in long COVID: roles, diagnostic biomarker potential and detection

Naomi-Eunicia Paval1,2, Olga Adriana Căliman-Sturdza3, Andrei Lobiuc4

  • 1Doctoral School, University of Medicine and Pharmacy "Victor Babes", 300041, Timisoara, Romania.

Human Genomics
|August 14, 2025
PubMed

Insights

Long COVID, or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), involves persistent symptoms affecting multiple organ systems. Oxford Nanopore Sequencing offers a promising method for studying microRNAs involved in PASC pathogenesis.

Area of Science:

  • Biomedical Research
  • Molecular Biology
  • Genomics

Background:

  • Long COVID (Post-Acute Sequelae of SARS-CoV-2 Infection - PASC) presents persistent symptoms impacting multiple organ systems.
  • Pathogenesis involves chronic inflammation, immune dysregulation, and direct viral injury, with microRNAs (miRNAs) playing a key regulatory role.
  • Conventional miRNA detection methods have limitations in sensitivity, throughput, and preserving native RNA modifications.

Purpose of the Study:

  • To review the role of microRNAs in Long COVID pathogenesis.
  • To highlight Oxford Nanopore Sequencing (ONS) as an advanced technique for miRNA profiling in Long COVID.
  • To discuss the potential of ONS for discovering novel regulatory interactions and biomarkers.

Main Methods:

  • Review of existing literature on Long COVID, miRNA biology, and sequencing technologies.
  • Focus on the capabilities of Oxford Nanopore Sequencing (ONS) for direct, real-time, amplification-free RNA sequencing.
  • Discussion of ONS advantages for analyzing full-length miRNAs and their precursors, including native modifications.

Main Results:

  • Altered miRNA expression is implicated in the pathogenesis of Long COVID.
  • ONS provides a novel approach for comprehensive miRNA analysis, overcoming limitations of conventional methods.
  • ONS enables the study of miRNA processing and regulatory functions with preserved native modifications.

Conclusions:

  • MicroRNAs are critical players in the complex mechanisms underlying Long COVID.
  • Oxford Nanopore Sequencing presents a powerful tool for advancing miRNA research in Long COVID.
  • ONS has the potential to accelerate the discovery of diagnostic biomarkers and therapeutic targets for Long COVID.